Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.6.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.238NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.68NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.74NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.237NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBNNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.462NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.147NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.6 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.5 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.4 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.420NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.39.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.233NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.320NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.635NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.19 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AM.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.15 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.113NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.88NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.98.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.34.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.124.1.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.203NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.8.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used